Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that using a person's own fat cells (SVF) can significantly increase hair thickness and density, suggesting it could be a promising treatment for hair loss.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

BB4CMU rice bran oil may help treat hair loss and gray hair.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

PRP is an effective and safe treatment for female hair loss.

Low-dose oral minoxidil is safe for treating children's hair disorders.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Natural products may help treat hair loss by promoting hair growth with fewer side effects.

Testosterone may influence COVID-19 severity and outcomes.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Possible link between COVID-19 and hair loss; more research needed.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

New understanding and treatments for hair loss are improving, but more research is needed.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Use antiandrogens and other treatments for hair loss.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.